GNPX
Genprex, Inc. Common Stock
stock NASDAQ

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.
The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.
They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱
#GNPX #Biotech #Stocks
https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/

They just announced they’ve secured a patent notice from IP Australia for the Reqorsa combo (locking down that market alongside the US & Korea) and they’ve opened a new trial site at the University of Kentucky.
The patent is great for the long-term moat, but honestly, the new trial site is the key here. More sites = faster enrollment = getting to that data sooner.
They are still targeting 2H 2026 for the interim analysis. Good to see them actually executing on the timeline. Bricks in the wall. 🧱
#GNPX #Biotech #Stocks
https://www.genprex.com/2026/02/10/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers/